Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,500.00
(
0.43%
)
Dow Jones
46,669.88
(
0.36%
)
Brent Oil
107.61
(
0.50%
)
Bitcoin
68,780.76
(
-0.11%
)
News Focus
News Focus
Post# of 257365
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: None

Thursday, 01/03/2013 9:02:35 AM

Thursday, January 03, 2013 9:02:35 AM

Post# of 257365
Abbott Labs (ABT +0.5%) launches its XIENCE Xpedition drug-eluting coronary stent, which slowly releases a medicine to block cell proliferation, after receiving FDA approval for the device. "XIENCE Xpedition represents a powerful combination of deliverability, strong clinical data and broad availability of meaningful sizes," says Dr Samin Sharma of Mount Sinai Medical Center in New York. (
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today